Stay updated with breaking news from Commodore Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Granted Breakthrough Therapy designation by the FDA for gedatolisib in HR+/HER2- advanced breast cancerEntered into agreements for the private placement sale of $100 million of equity and to increase available
IVERIC bio, Inc. (NASDAQ:ISEE – Get Rating) COO Keith Westby sold 9,298 shares of the stock in a transaction on Tuesday, April 5th. The shares were sold at an average price of $19.02, for a total value of $176,847.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available […]
Cogent Biosciences, Inc. (NASDAQ:COGT – Get Rating) shares passed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $6.72 and traded as high as $8.88. Cogent Biosciences shares last traded at $8.81, with a volume of 621,366 shares. Separately, Zacks Investment Research cut Cogent […]
IVERIC bio, Inc. (NASDAQ:ISEE – Get Rating) CFO David Francis Carroll sold 16,772 shares of IVERIC bio stock in a transaction on Friday, March 25th. The stock was sold at an average price of $17.02, for a total transaction of $285,459.44. The transaction was disclosed in a legal filing with the SEC, which can be […]
Zacks Investment Research lowered shares of IVERIC bio (NASDAQ:ISEE – Get Rating) from a buy rating to a sell rating in a research report released on Tuesday, Zacks.com reports. According to Zacks, “IVERIC bio Inc. is a biotechnology company. It is focused on the discovery and development of novel gene therapy solutions to treat orphan […]